Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449683 · ClinicalTrials.gov registry record · Phase 4
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00449683 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 23 participants.
The verdict
NCT00449683, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The study consists of measurement of antidepressant-induced excessive sweating and its treatment with an experimental medication, terazosin (approved for hypertension), that will be added to the antidepressant. This study is for people who take an antidepressant due to a depressive disorder. This is an open-label study (no placebo group) that will last 5 weeks, with one week of baseline measurement and four weeks of treatment with the study medication. The study is based on the hypothesis that terazosin will be effective in reducing the severity of excessive sweating caused by antidepressant treatment, and will have minimal side-effects.
Interventions
- DRUG terazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-03 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00449683
The ClinicalTrials.gov registry entry for NCT00449683 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which terazosin is the first listed.
NCT00449683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00449683 about?
NCT00449683 is a clinical study titled "Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin". The study consists of measurement of antidepressant-induced excessive sweating and its treatment with an experimental medication, terazosin (approved for hypertension), that will be added to the antidepressant. This study is for people who take an antidepressant due to a depressive disorder. This is...
What is the current status of trial NCT00449683?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2007-03. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00449683?
The interventions under investigation include: terazosin (DRUG).
Who is sponsoring clinical trial NCT00449683?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.